Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Form 8.5 (EPT/RI) - Replacement - Pfizer Inc

2nd May 2014 14:07

RNS Number : 2111G
Morgan Stanley Capital Services LLC
02 May 2014
 

AMENDMENT

 

 FORM 8.5 (EPT/RI)

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Morgan Stanley Capital Services LLC

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

PFIZER INC

(c) Name of the party to the offer with which exempt principal trader is connected:

 

ASTRAZENECA PLC

(d) Date dealing undertaken:

29 APRIL 2014

(e) Has the EPT previously disclosed, or is it today disclosing, under the Code in respect of any other party to this offer?

Yes

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

(a) Purchases and sales

 

 Class of relevant security

 Purchases/sales

 Total number of securities

 Highest price per unit paid/received

 Lowest price per unit paid/received

 COMMON STOCK

 PURCHASES

 986,191

 32.0400 USD

 31.4100 USD

 COMMON STOCK

 SALES

 168,496

 32.0600 USD

 31.4100 USD

 

 

(b) Derivatives transactions (other than options)

 

 Class of relevant security

 Product description

e.g. CFD

 Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

 Number of reference securities

 Price per unit

 COMMON STOCK

 CFD

 LONG

 200

 31.5250 USD

 COMMON STOCK

 CFD

 LONG

 13,941

 31.5916 USD

 COMMON STOCK

 CFD

 LONG

 4,100

 31.6376 USD

 COMMON STOCK

 CFD

 LONG

 50,900

 31.6376 USD

 COMMON STOCK

 CFD

 LONG

 42,300

 31.6514 USD

 COMMON STOCK

 CFD

 LONG

 400

 31.6650 USD

 COMMON STOCK

 CFD

 LONG

 1,000

 31.6904 USD

 COMMON STOCK

 CFD

 LONG

 4,600

 31.7650 USD

 COMMON STOCK

 CFD

 SHORT

 14,404

 31.5349 USD

 COMMON STOCK

 CFD

 SHORT

 6,700

 31.5420 USD

 COMMON STOCK

 CFD

 SHORT

 2,992

 31.5456 USD

 COMMON STOCK

 CFD

 SHORT

 19,354

 31.5457 USD

 COMMON STOCK

 CFD

 SHORT

 85

 31.5490 USD

 COMMON STOCK

 CFD

 SHORT

 14

 31.5490 USD

 COMMON STOCK

 CFD

 SHORT

 1,800

 31.5500 USD

 COMMON STOCK

 CFD

 SHORT

 6,400

 31.5735 USD

 COMMON STOCK

 CFD

 SHORT

 1,394

 31.5910 USD

 COMMON STOCK

 CFD

 SHORT

 215

 31.5910 USD

 COMMON STOCK

 CFD

 SHORT

 15,522

 31.5910 USD

 COMMON STOCK

 CFD

 SHORT

 2,401

 31.5910 USD

 COMMON STOCK

 CFD

 SHORT

 30,600

 31.5955 USD

 COMMON STOCK

 CFD

 SHORT

 6,794

 31.6584 USD

 COMMON STOCK

 CFD

 SHORT

 910

 31.6584 USD

 COMMON STOCK

 CFD

 SHORT

 72,883

 31.6591 USD

 COMMON STOCK

 CFD

 SHORT

 2,724

 31.6592 USD

 COMMON STOCK

 CFD

 SHORT

 530

 31.6592 USD

 COMMON STOCK

 CFD

 SHORT

 299

 31.6595 USD

 COMMON STOCK

 CFD

 SHORT

 1,200

 31.6595 USD

 COMMON STOCK

 CFD

 SHORT

 3,645

 31.6606 USD

 COMMON STOCK

 CFD

 SHORT

 908

 31.6606 USD

 COMMON STOCK

 CFD

 SHORT

 177,500

 31.6684 USD

 COMMON STOCK

 CFD

 SHORT

 10,501

 31.6948 USD

 COMMON STOCK

 CFD

 SHORT

 955

 31.6949 USD

 COMMON STOCK

 CFD

 SHORT

 2,030

 31.7147 USD

 COMMON STOCK

 CFD

 SHORT

 3,100

 31.7451 USD

 COMMON STOCK

 CFD

 SHORT

 1,460

 31.7600 USD

 COMMON STOCK

 CFD

 SHORT

 47,000

 31.7600 USD

 COMMON STOCK

 CFD

 SHORT

 26,742

 31.8030 USD

 COMMON STOCK

 CFD

 SHORT

 519,900

 32.0400 USD

 

 

(c) Options transactions in respect of existing securities

 

(i) Writing, selling, purchasing or varying

 

 Class of relevant security

 Product description e.g. call option

 Writing, purchasing, selling, varying etc.

 Number of securities to which option relates

 Exercise price per unit

 Type e.g. American, European etc.

 Expiry date

 Option money paid/ received per unit

 N/A

 N/A

 N/A

 N/A

 N/A

 N/A

 N/A

 N/A

 

(ii) Exercising

 

 Class of relevant security

 Product description e.g. call option

 Number of securities

 Exercise price per unit

 N/A

 N/A

 N/A

 N/A

 

(d) Other dealings (including subscribing for new securities)

 

 Class of relevant security

 Nature of dealing e.g. subscription, conversion

 Details

 Price per unit (if applicable)

 N/A

 N/A

 N/A

 N/A

 

The currency of all prices and other monetary amounts should be stated.

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

 

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

 

 

Date of disclosure:

02 MAY 2014

Contact name:

Darren Wickert

Telephone number:

+44 (0)20 7425 6578

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FERQKBDKNBKDAPK

Related Shares:

AstrazenecaPFZ.L
FTSE 100 Latest
Value8,705.23
Change24.94